Who owns Mirum Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MIRM from SEC Form 13F filings across 318 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 318 institutions disclosed 71.9M shares of Mirum Pharmaceuticals, Inc. worth $6.17B — about 109.8% of shares outstanding; the largest disclosed holder is Frazier Life Sciences Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
318
13F holders
$6.17B
value, 2026 filers
109.8%
of shares outstanding (71.9M sh)
50
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MIRM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 7.7M | $656.5M | 16.3% | 11.7% | 0.0% |
| 2 | Janus Henderson Group Ltd.NEW | 5.5M | $473.3M | 0.2% | 8.5% | new |
| 3 | BlackRock, Inc. | 4.7M | $403.7M | 0.0% | 7.2% | +7.6% |
| 4 | FMR LLC | 4.1M | $348.2M | 0.0% | 6.2% | +11.0% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.6M | $225.1M | 0.0% | 4% | +10.8% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.5M | $217.5M | 0.0% | 3.9% | -4.2% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | $213.6M | 0.0% | 3.8% | +10.8% |
| 8 | STATE STREET CORP | 2.4M | $204.4M | 0.0% | 3.6% | +10.1% |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | 1.7M | $144.3M | 0.0% | 2.6% | +28.9% |
| 10 | Invesco Ltd. | 1.5M | $131.2M | 0.0% | 2.3% | +12.5% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $124.0M | 0.0% | 2.2% | +4.1% |
| 12 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.4M | $118.2M | 0.4% | 2.1% | -1.5% |
| 13 | FRANKLIN TEMPLETON INC | 1.3M | $121.9M | 0.0% | 1.9% | +9.1% |
| 14 | EVENTIDE ASSET MANAGEMENT, LLC | 1.2M | $106.7M | 1.5% | 1.9% | 0.0% |
| 15 | TANG CAPITAL MANAGEMENT LLC | 1.2M | $105.7M | 4.9% | 1.9% | 0.0% |
| 16 | Capital World Investors | 1.2M | $98.6M | 0.0% | 1.8% | 0.0% |
| 17 | NOVO HOLDINGS A/S | 1.1M | $96.2M | 6.5% | 1.7% | 0.0% |
| 18 | TCG Crossover Management, LLC | 1.1M | $95.6M | 2.7% | 1.7% | +5.4% |
| 19 | AMERIPRISE FINANCIAL INC | 900,736 | $77.0M | 0.0% | 1.4% | +23.9% |
| 20 | TWO SIGMA INVESTMENTS, LP | 851,785 | $72.8M | 0.1% | 1.3% | +23.4% |
| 21 | Polar Capital Holdings Plc | 843,048 | $72.1M | 0.2% | 1.3% | -0.3% |
| 22 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 810,427 | $69.3M | 0.1% | 1.2% | +7.8% |
| 23 | Rock Springs Capital Management LP | 779,790 | $66.7M | 3.6% | 1.2% | -2.3% |
| 24 | Bank of New York Mellon Corp | 744,702 | $63.7M | 0.0% | 1.1% | +11.2% |
| 25 | UBS Group AG | 722,143 | $61.7M | 0.0% | 1.1% | +90.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.